nodes	percent_of_prediction	percent_of_DWPC	metapath
Estriol—ESR2—urinary bladder cancer	0.426	0.619	CbGaD
Estriol—ESR1—urinary bladder cancer	0.263	0.381	CbGaD
Estriol—ABCB1—Mitomycin—urinary bladder cancer	0.0684	0.403	CbGbCtD
Estriol—SLCO1A2—Methotrexate—urinary bladder cancer	0.0344	0.202	CbGbCtD
Estriol—ABCB1—Gemcitabine—urinary bladder cancer	0.0197	0.116	CbGbCtD
Estriol—ABCB1—Cisplatin—urinary bladder cancer	0.0143	0.0843	CbGbCtD
Estriol—ABCB1—Etoposide—urinary bladder cancer	0.0141	0.0828	CbGbCtD
Estriol—ABCB1—Doxorubicin—urinary bladder cancer	0.00959	0.0565	CbGbCtD
Estriol—ABCB1—Methotrexate—urinary bladder cancer	0.00929	0.0547	CbGbCtD
Estriol—ESR2—prostate gland—urinary bladder cancer	0.00163	0.0868	CbGeAlD
Estriol—SHBG—prostate gland—urinary bladder cancer	0.00158	0.0844	CbGeAlD
Estriol—ESR2—epithelium—urinary bladder cancer	0.0012	0.0638	CbGeAlD
Estriol—ESR2—smooth muscle tissue—urinary bladder cancer	0.00115	0.0615	CbGeAlD
Estriol—ESR1—prostate gland—urinary bladder cancer	0.00112	0.0595	CbGeAlD
Estriol—ESR2—renal system—urinary bladder cancer	0.00111	0.0592	CbGeAlD
Estriol—SLCO1A2—renal system—urinary bladder cancer	0.000896	0.0478	CbGeAlD
Estriol—ESR2—female reproductive system—urinary bladder cancer	0.000889	0.0474	CbGeAlD
Estriol—SHBG—female reproductive system—urinary bladder cancer	0.000864	0.0461	CbGeAlD
Estriol—ESR1—epithelium—urinary bladder cancer	0.00082	0.0437	CbGeAlD
Estriol—ESR2—vagina—urinary bladder cancer	0.000804	0.0429	CbGeAlD
Estriol—ESR1—smooth muscle tissue—urinary bladder cancer	0.00079	0.0421	CbGeAlD
Estriol—SHBG—vagina—urinary bladder cancer	0.000781	0.0417	CbGeAlD
Estriol—ESR1—renal system—urinary bladder cancer	0.00076	0.0405	CbGeAlD
Estriol—Quinestrol—ESR1—urinary bladder cancer	0.000722	0.126	CrCbGaD
Estriol—Estramustine—ESR2—urinary bladder cancer	0.00072	0.126	CrCbGaD
Estriol—ESR1—female reproductive system—urinary bladder cancer	0.000609	0.0325	CbGeAlD
Estriol—Estropipate—ESR2—urinary bladder cancer	0.000592	0.104	CrCbGaD
Estriol—ESR1—vagina—urinary bladder cancer	0.000551	0.0294	CbGeAlD
Estriol—Mestranol—ESR1—urinary bladder cancer	0.000547	0.0956	CrCbGaD
Estriol—ESR2—lymph node—urinary bladder cancer	0.00052	0.0277	CbGeAlD
Estriol—Estramustine—ESR1—urinary bladder cancer	0.000444	0.0776	CrCbGaD
Estriol—ABCB1—prostate gland—urinary bladder cancer	0.00044	0.0235	CbGeAlD
Estriol—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000423	0.074	CrCbGaD
Estriol—ABCB1—seminal vesicle—urinary bladder cancer	0.000373	0.0199	CbGeAlD
Estriol—Conjugated Estrogens—ESR2—urinary bladder cancer	0.00037	0.0646	CrCbGaD
Estriol—Estrone—ESR2—urinary bladder cancer	0.000369	0.0645	CrCbGaD
Estriol—Estropipate—ESR1—urinary bladder cancer	0.000365	0.0638	CrCbGaD
Estriol—ESR1—lymph node—urinary bladder cancer	0.000356	0.019	CbGeAlD
Estriol—ABCB1—epithelium—urinary bladder cancer	0.000324	0.0173	CbGeAlD
Estriol—ABCB1—renal system—urinary bladder cancer	0.0003	0.016	CbGeAlD
Estriol—ABCB1—urethra—urinary bladder cancer	0.000295	0.0157	CbGeAlD
Estriol—Estradiol—ESR2—urinary bladder cancer	0.000279	0.0489	CrCbGaD
Estriol—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000261	0.0456	CrCbGaD
Estriol—ABCB1—female reproductive system—urinary bladder cancer	0.00024	0.0128	CbGeAlD
Estriol—Conjugated Estrogens—ESR1—urinary bladder cancer	0.000228	0.0398	CrCbGaD
Estriol—Estrone—ESR1—urinary bladder cancer	0.000227	0.0397	CrCbGaD
Estriol—ABCB1—vagina—urinary bladder cancer	0.000217	0.0116	CbGeAlD
Estriol—Abnormal vision—Epirubicin—urinary bladder cancer	0.000206	0.00252	CcSEcCtD
Estriol—Nervous system disorder—Thiotepa—urinary bladder cancer	0.000206	0.00251	CcSEcCtD
Estriol—Alopecia—Cisplatin—urinary bladder cancer	0.000204	0.00249	CcSEcCtD
Estriol—Skin disorder—Thiotepa—urinary bladder cancer	0.000204	0.00248	CcSEcCtD
Estriol—Malnutrition—Cisplatin—urinary bladder cancer	0.000201	0.00246	CcSEcCtD
Estriol—Cramps of lower extremities—Doxorubicin—urinary bladder cancer	0.000201	0.00245	CcSEcCtD
Estriol—Erythema multiforme—Etoposide—urinary bladder cancer	0.0002	0.00244	CcSEcCtD
Estriol—Flatulence—Cisplatin—urinary bladder cancer	0.000198	0.00242	CcSEcCtD
Estriol—Thrombophlebitis—Epirubicin—urinary bladder cancer	0.000198	0.00242	CcSEcCtD
Estriol—Eye disorder—Etoposide—urinary bladder cancer	0.000198	0.00242	CcSEcCtD
Estriol—Neoplasm—Doxorubicin—urinary bladder cancer	0.000198	0.00241	CcSEcCtD
Estriol—Cardiac disorder—Etoposide—urinary bladder cancer	0.000197	0.0024	CcSEcCtD
Estriol—Visual disturbance—Methotrexate—urinary bladder cancer	0.000194	0.00236	CcSEcCtD
Estriol—Muscle spasms—Cisplatin—urinary bladder cancer	0.000194	0.00236	CcSEcCtD
Estriol—Angiopathy—Etoposide—urinary bladder cancer	0.000192	0.00235	CcSEcCtD
Estriol—Vascular purpura—Epirubicin—urinary bladder cancer	0.000192	0.00234	CcSEcCtD
Estriol—Immune system disorder—Etoposide—urinary bladder cancer	0.000191	0.00234	CcSEcCtD
Estriol—Abnormal vision—Doxorubicin—urinary bladder cancer	0.000191	0.00233	CcSEcCtD
Estriol—Cardiac failure congestive—Epirubicin—urinary bladder cancer	0.000189	0.00231	CcSEcCtD
Estriol—Alopecia—Etoposide—urinary bladder cancer	0.000187	0.00228	CcSEcCtD
Estriol—Cerebrovascular accident—Methotrexate—urinary bladder cancer	0.000187	0.00228	CcSEcCtD
Estriol—Hypertension—Gemcitabine—urinary bladder cancer	0.000186	0.00228	CcSEcCtD
Estriol—Dyspepsia—Thiotepa—urinary bladder cancer	0.000184	0.00225	CcSEcCtD
Estriol—Thrombophlebitis—Doxorubicin—urinary bladder cancer	0.000184	0.00224	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.000183	0.00223	CcSEcCtD
Estriol—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.000181	0.00221	CcSEcCtD
Estriol—Pain—Thiotepa—urinary bladder cancer	0.000179	0.00219	CcSEcCtD
Estriol—Back pain—Etoposide—urinary bladder cancer	0.000178	0.00218	CcSEcCtD
Estriol—Vascular purpura—Doxorubicin—urinary bladder cancer	0.000178	0.00217	CcSEcCtD
Estriol—Muscle spasms—Etoposide—urinary bladder cancer	0.000177	0.00216	CcSEcCtD
Estriol—Anaphylactic shock—Gemcitabine—urinary bladder cancer	0.000176	0.00215	CcSEcCtD
Estriol—Oedema—Gemcitabine—urinary bladder cancer	0.000176	0.00215	CcSEcCtD
Estriol—Cerebrovascular accident—Epirubicin—urinary bladder cancer	0.000175	0.00214	CcSEcCtD
Estriol—Cardiac failure congestive—Doxorubicin—urinary bladder cancer	0.000175	0.00214	CcSEcCtD
Estriol—Infection—Gemcitabine—urinary bladder cancer	0.000175	0.00214	CcSEcCtD
Estriol—Anaphylactic shock—Fluorouracil—urinary bladder cancer	0.000173	0.00212	CcSEcCtD
Estriol—Oedema—Fluorouracil—urinary bladder cancer	0.000173	0.00212	CcSEcCtD
Estriol—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.000173	0.00211	CcSEcCtD
Estriol—Infection—Fluorouracil—urinary bladder cancer	0.000172	0.0021	CcSEcCtD
Estriol—Estradiol—ESR1—urinary bladder cancer	0.000172	0.0301	CrCbGaD
Estriol—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000171	0.00209	CcSEcCtD
Estriol—Skin disorder—Gemcitabine—urinary bladder cancer	0.000171	0.00209	CcSEcCtD
Estriol—Anxiety—Cisplatin—urinary bladder cancer	0.000171	0.00208	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00017	0.00208	CcSEcCtD
Estriol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00017	0.00207	CcSEcCtD
Estriol—Migraine—Epirubicin—urinary bladder cancer	0.000169	0.00206	CcSEcCtD
Estriol—Urticaria—Thiotepa—urinary bladder cancer	0.000166	0.00203	CcSEcCtD
Estriol—Breast disorder—Methotrexate—urinary bladder cancer	0.000166	0.00202	CcSEcCtD
Estriol—Abdominal pain—Thiotepa—urinary bladder cancer	0.000166	0.00202	CcSEcCtD
Estriol—Anaphylactic shock—Cisplatin—urinary bladder cancer	0.000164	0.00201	CcSEcCtD
Estriol—Oedema—Cisplatin—urinary bladder cancer	0.000164	0.00201	CcSEcCtD
Estriol—Infection—Cisplatin—urinary bladder cancer	0.000163	0.00199	CcSEcCtD
Estriol—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	0.000162	0.00198	CcSEcCtD
Estriol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000161	0.00197	CcSEcCtD
Estriol—Skin disorder—Cisplatin—urinary bladder cancer	0.00016	0.00195	CcSEcCtD
Estriol—Insomnia—Gemcitabine—urinary bladder cancer	0.000159	0.00195	CcSEcCtD
Estriol—Hypertension—Etoposide—urinary bladder cancer	0.000159	0.00194	CcSEcCtD
Estriol—Asthma—Methotrexate—urinary bladder cancer	0.000159	0.00193	CcSEcCtD
Estriol—Insomnia—Fluorouracil—urinary bladder cancer	0.000157	0.00191	CcSEcCtD
Estriol—Migraine—Doxorubicin—urinary bladder cancer	0.000156	0.00191	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000156	0.0019	CcSEcCtD
Estriol—Breast disorder—Epirubicin—urinary bladder cancer	0.000155	0.00189	CcSEcCtD
Estriol—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000154	0.00188	CcSEcCtD
Estriol—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000153	0.00186	CcSEcCtD
Estriol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000152	0.00186	CcSEcCtD
Estriol—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000152	0.00185	CcSEcCtD
Estriol—Pain—Gemcitabine—urinary bladder cancer	0.000151	0.00184	CcSEcCtD
Estriol—Anaphylactic shock—Etoposide—urinary bladder cancer	0.000151	0.00184	CcSEcCtD
Estriol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00015	0.00183	CcSEcCtD
Estriol—Infection—Etoposide—urinary bladder cancer	0.00015	0.00182	CcSEcCtD
Estriol—Abdominal distension—Epirubicin—urinary bladder cancer	0.000149	0.00182	CcSEcCtD
Estriol—Asthma—Epirubicin—urinary bladder cancer	0.000148	0.00181	CcSEcCtD
Estriol—Pruritus—Thiotepa—urinary bladder cancer	0.000148	0.00181	CcSEcCtD
Estriol—Pain—Fluorouracil—urinary bladder cancer	0.000148	0.00181	CcSEcCtD
Estriol—Skin disorder—Etoposide—urinary bladder cancer	0.000146	0.00178	CcSEcCtD
Estriol—Breast disorder—Doxorubicin—urinary bladder cancer	0.000144	0.00175	CcSEcCtD
Estriol—Diarrhoea—Thiotepa—urinary bladder cancer	0.000143	0.00175	CcSEcCtD
Estriol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000142	0.00173	CcSEcCtD
Estriol—Infestation—Methotrexate—urinary bladder cancer	0.000141	0.00173	CcSEcCtD
Estriol—Infestation NOS—Methotrexate—urinary bladder cancer	0.000141	0.00173	CcSEcCtD
Estriol—Depression—Methotrexate—urinary bladder cancer	0.000141	0.00172	CcSEcCtD
Estriol—ABCB1—lymph node—urinary bladder cancer	0.000141	0.0075	CbGeAlD
Estriol—Pain—Cisplatin—urinary bladder cancer	0.000141	0.00171	CcSEcCtD
Estriol—Dizziness—Thiotepa—urinary bladder cancer	0.000139	0.00169	CcSEcCtD
Estriol—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000138	0.00169	CcSEcCtD
Estriol—Urticaria—Fluorouracil—urinary bladder cancer	0.000138	0.00168	CcSEcCtD
Estriol—Asthma—Doxorubicin—urinary bladder cancer	0.000137	0.00168	CcSEcCtD
Estriol—Weight increased—Epirubicin—urinary bladder cancer	0.000135	0.00165	CcSEcCtD
Estriol—Weight decreased—Epirubicin—urinary bladder cancer	0.000134	0.00164	CcSEcCtD
Estriol—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000134	0.00163	CcSEcCtD
Estriol—Vomiting—Thiotepa—urinary bladder cancer	0.000133	0.00163	CcSEcCtD
Estriol—Infestation NOS—Epirubicin—urinary bladder cancer	0.000132	0.00161	CcSEcCtD
Estriol—Infestation—Epirubicin—urinary bladder cancer	0.000132	0.00161	CcSEcCtD
Estriol—Rash—Thiotepa—urinary bladder cancer	0.000132	0.00161	CcSEcCtD
Estriol—Dermatitis—Thiotepa—urinary bladder cancer	0.000132	0.00161	CcSEcCtD
Estriol—Headache—Thiotepa—urinary bladder cancer	0.000131	0.0016	CcSEcCtD
Estriol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00013	0.00159	CcSEcCtD
Estriol—Pain—Etoposide—urinary bladder cancer	0.000129	0.00157	CcSEcCtD
Estriol—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000128	0.00156	CcSEcCtD
Estriol—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000125	0.00153	CcSEcCtD
Estriol—Weight increased—Doxorubicin—urinary bladder cancer	0.000125	0.00152	CcSEcCtD
Estriol—Pruritus—Gemcitabine—urinary bladder cancer	0.000125	0.00152	CcSEcCtD
Estriol—Nausea—Thiotepa—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Estriol—Weight decreased—Doxorubicin—urinary bladder cancer	0.000124	0.00152	CcSEcCtD
Estriol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000123	0.0015	CcSEcCtD
Estriol—Pruritus—Fluorouracil—urinary bladder cancer	0.000123	0.0015	CcSEcCtD
Estriol—Infestation—Doxorubicin—urinary bladder cancer	0.000122	0.00149	CcSEcCtD
Estriol—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000122	0.00149	CcSEcCtD
Estriol—Visual impairment—Methotrexate—urinary bladder cancer	0.000122	0.00149	CcSEcCtD
Estriol—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000121	0.00148	CcSEcCtD
Estriol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000121	0.00147	CcSEcCtD
Estriol—Erythema multiforme—Methotrexate—urinary bladder cancer	0.00012	0.00146	CcSEcCtD
Estriol—Urticaria—Etoposide—urinary bladder cancer	0.00012	0.00146	CcSEcCtD
Estriol—Abdominal pain—Etoposide—urinary bladder cancer	0.000119	0.00145	CcSEcCtD
Estriol—Eye disorder—Methotrexate—urinary bladder cancer	0.000119	0.00145	CcSEcCtD
Estriol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000119	0.00145	CcSEcCtD
Estriol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000118	0.00144	CcSEcCtD
Estriol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000117	0.00143	CcSEcCtD
Estriol—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000117	0.00142	CcSEcCtD
Estriol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000116	0.00141	CcSEcCtD
Estriol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000116	0.00328	CbGpPWpGaD
Estriol—Angiopathy—Methotrexate—urinary bladder cancer	0.000115	0.00141	CcSEcCtD
Estriol—Immune system disorder—Methotrexate—urinary bladder cancer	0.000115	0.0014	CcSEcCtD
Estriol—Dizziness—Fluorouracil—urinary bladder cancer	0.000115	0.0014	CcSEcCtD
Estriol—Visual impairment—Epirubicin—urinary bladder cancer	0.000114	0.0014	CcSEcCtD
Estriol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000112	0.00137	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000112	0.00319	CbGpPWpGaD
Estriol—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000112	0.00137	CcSEcCtD
Estriol—Alopecia—Methotrexate—urinary bladder cancer	0.000112	0.00137	CcSEcCtD
Estriol—Vomiting—Gemcitabine—urinary bladder cancer	0.000112	0.00137	CcSEcCtD
Estriol—Mental disorder—Methotrexate—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Estriol—Rash—Gemcitabine—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Estriol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000111	0.00136	CcSEcCtD
Estriol—Eye disorder—Epirubicin—urinary bladder cancer	0.000111	0.00135	CcSEcCtD
Estriol—Hypersensitivity—Etoposide—urinary bladder cancer	0.000111	0.00135	CcSEcCtD
Estriol—Malnutrition—Methotrexate—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Estriol—Headache—Gemcitabine—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Estriol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.00011	0.00135	CcSEcCtD
Estriol—Vomiting—Fluorouracil—urinary bladder cancer	0.00011	0.00134	CcSEcCtD
Estriol—Rash—Fluorouracil—urinary bladder cancer	0.000109	0.00133	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000109	0.0031	CbGpPWpGaD
Estriol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000109	0.00133	CcSEcCtD
Estriol—Headache—Fluorouracil—urinary bladder cancer	0.000109	0.00133	CcSEcCtD
Estriol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000108	0.00132	CcSEcCtD
Estriol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000108	0.00132	CcSEcCtD
Estriol—Angiopathy—Epirubicin—urinary bladder cancer	0.000108	0.00131	CcSEcCtD
Estriol—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.000107	0.00304	CbGpPWpGaD
Estriol—Immune system disorder—Epirubicin—urinary bladder cancer	0.000107	0.00131	CcSEcCtD
Estriol—Back pain—Methotrexate—urinary bladder cancer	0.000107	0.0013	CcSEcCtD
Estriol—Pruritus—Etoposide—urinary bladder cancer	0.000106	0.0013	CcSEcCtD
Estriol—Visual impairment—Doxorubicin—urinary bladder cancer	0.000106	0.00129	CcSEcCtD
Estriol—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.000105	0.00299	CbGpPWpGaD
Estriol—Alopecia—Epirubicin—urinary bladder cancer	0.000105	0.00128	CcSEcCtD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000105	0.00298	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	0.000105	0.00297	CbGpPWpGaD
Estriol—Nausea—Gemcitabine—urinary bladder cancer	0.000105	0.00128	CcSEcCtD
Estriol—Vomiting—Cisplatin—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Estriol—Mental disorder—Epirubicin—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Estriol—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000104	0.00127	CcSEcCtD
Estriol—Rash—Cisplatin—urinary bladder cancer	0.000104	0.00126	CcSEcCtD
Estriol—Dermatitis—Cisplatin—urinary bladder cancer	0.000104	0.00126	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	0.000103	0.00293	CbGpPWpGaD
Estriol—Malnutrition—Epirubicin—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Estriol—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000103	0.00293	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000103	0.00293	CbGpPWpGaD
Estriol—Diarrhoea—Etoposide—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Estriol—Nausea—Fluorouracil—urinary bladder cancer	0.000103	0.00126	CcSEcCtD
Estriol—Eye disorder—Doxorubicin—urinary bladder cancer	0.000103	0.00125	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.000102	0.0029	CbGpPWpGaD
Estriol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000102	0.00124	CcSEcCtD
Estriol—Flatulence—Epirubicin—urinary bladder cancer	0.000102	0.00124	CcSEcCtD
Estriol—Tension—Epirubicin—urinary bladder cancer	0.000101	0.00124	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000101	0.00286	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000101	0.00285	CbGpPWpGaD
Estriol—Nervousness—Epirubicin—urinary bladder cancer	0.0001	0.00123	CcSEcCtD
Estriol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.0001	0.00284	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.0001	0.00284	CbGpPWpGaD
Estriol—Back pain—Epirubicin—urinary bladder cancer	0.0001	0.00122	CcSEcCtD
Estriol—Angiopathy—Doxorubicin—urinary bladder cancer	9.97e-05	0.00122	CcSEcCtD
Estriol—Dizziness—Etoposide—urinary bladder cancer	9.95e-05	0.00121	CcSEcCtD
Estriol—Muscle spasms—Epirubicin—urinary bladder cancer	9.94e-05	0.00121	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.94e-05	0.00282	CbGpPWpGaD
Estriol—Immune system disorder—Doxorubicin—urinary bladder cancer	9.93e-05	0.00121	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	9.92e-05	0.00281	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	9.79e-05	0.00278	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	9.78e-05	0.00277	CbGpPWpGaD
Estriol—Nausea—Cisplatin—urinary bladder cancer	9.76e-05	0.00119	CcSEcCtD
Estriol—Alopecia—Doxorubicin—urinary bladder cancer	9.71e-05	0.00119	CcSEcCtD
Estriol—Mental disorder—Doxorubicin—urinary bladder cancer	9.63e-05	0.00117	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	9.58e-05	0.00272	CbGpPWpGaD
Estriol—Vomiting—Etoposide—urinary bladder cancer	9.57e-05	0.00117	CcSEcCtD
Estriol—Malnutrition—Doxorubicin—urinary bladder cancer	9.57e-05	0.00117	CcSEcCtD
Estriol—Rash—Etoposide—urinary bladder cancer	9.49e-05	0.00116	CcSEcCtD
Estriol—Dermatitis—Etoposide—urinary bladder cancer	9.48e-05	0.00116	CcSEcCtD
Estriol—Headache—Etoposide—urinary bladder cancer	9.43e-05	0.00115	CcSEcCtD
Estriol—Flatulence—Doxorubicin—urinary bladder cancer	9.43e-05	0.00115	CcSEcCtD
Estriol—Tension—Doxorubicin—urinary bladder cancer	9.39e-05	0.00115	CcSEcCtD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	9.37e-05	0.00266	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	9.37e-05	0.00266	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	9.35e-05	0.00265	CbGpPWpGaD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	9.34e-05	0.00114	CcSEcCtD
Estriol—Nervousness—Doxorubicin—urinary bladder cancer	9.29e-05	0.00113	CcSEcCtD
Estriol—Back pain—Doxorubicin—urinary bladder cancer	9.25e-05	0.00113	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	9.21e-05	0.00261	CbGpPWpGaD
Estriol—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	9.21e-05	0.00261	CbGpPWpGaD
Estriol—Muscle spasms—Doxorubicin—urinary bladder cancer	9.2e-05	0.00112	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	9.16e-05	0.0026	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	9.12e-05	0.00259	CbGpPWpGaD
Estriol—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	9.05e-05	0.00257	CbGpPWpGaD
Estriol—Anaphylactic shock—Methotrexate—urinary bladder cancer	9.02e-05	0.0011	CcSEcCtD
Estriol—Infection—Methotrexate—urinary bladder cancer	8.96e-05	0.00109	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	8.95e-05	0.00254	CbGpPWpGaD
Estriol—Nausea—Etoposide—urinary bladder cancer	8.94e-05	0.00109	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	8.93e-05	0.00253	CbGpPWpGaD
Estriol—Hypertension—Epirubicin—urinary bladder cancer	8.93e-05	0.00109	CcSEcCtD
Estriol—Nervous system disorder—Methotrexate—urinary bladder cancer	8.84e-05	0.00108	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	8.77e-05	0.00249	CbGpPWpGaD
Estriol—Anxiety—Epirubicin—urinary bladder cancer	8.77e-05	0.00107	CcSEcCtD
Estriol—Skin disorder—Methotrexate—urinary bladder cancer	8.76e-05	0.00107	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	8.74e-05	0.00107	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	8.73e-05	0.00247	CbGpPWpGaD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	8.63e-05	0.00245	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	8.62e-05	0.00244	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	8.58e-05	0.00243	CbGpPWpGaD
Estriol—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	8.49e-05	0.00241	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	8.47e-05	0.0024	CbGpPWpGaD
Estriol—Anaphylactic shock—Epirubicin—urinary bladder cancer	8.44e-05	0.00103	CcSEcCtD
Estriol—Oedema—Epirubicin—urinary bladder cancer	8.44e-05	0.00103	CcSEcCtD
Estriol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	8.43e-05	0.00239	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	8.42e-05	0.00239	CbGpPWpGaD
Estriol—ESR2—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	8.39e-05	0.00238	CbGpPWpGaD
Estriol—Infection—Epirubicin—urinary bladder cancer	8.38e-05	0.00102	CcSEcCtD
Estriol—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	8.37e-05	0.00237	CbGpPWpGaD
Estriol—Shock—Epirubicin—urinary bladder cancer	8.3e-05	0.00101	CcSEcCtD
Estriol—Nervous system disorder—Epirubicin—urinary bladder cancer	8.27e-05	0.00101	CcSEcCtD
Estriol—Hypertension—Doxorubicin—urinary bladder cancer	8.26e-05	0.00101	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	8.26e-05	0.00234	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	8.2e-05	0.00233	CbGpPWpGaD
Estriol—Skin disorder—Epirubicin—urinary bladder cancer	8.2e-05	0.001	CcSEcCtD
Estriol—Insomnia—Methotrexate—urinary bladder cancer	8.15e-05	0.000995	CcSEcCtD
Estriol—Anxiety—Doxorubicin—urinary bladder cancer	8.12e-05	0.00099	CcSEcCtD
Estriol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	8.09e-05	0.000987	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	8.03e-05	0.00228	CbGpPWpGaD
Estriol—Dyspepsia—Methotrexate—urinary bladder cancer	7.94e-05	0.000969	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.9e-05	0.00224	CbGpPWpGaD
Estriol—Anaphylactic shock—Doxorubicin—urinary bladder cancer	7.81e-05	0.000953	CcSEcCtD
Estriol—Oedema—Doxorubicin—urinary bladder cancer	7.81e-05	0.000953	CcSEcCtD
Estriol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	7.78e-05	0.00095	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.76e-05	0.0022	CbGpPWpGaD
Estriol—Infection—Doxorubicin—urinary bladder cancer	7.76e-05	0.000947	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.75e-05	0.0022	CbGpPWpGaD
Estriol—Pain—Methotrexate—urinary bladder cancer	7.71e-05	0.000941	CcSEcCtD
Estriol—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	7.69e-05	0.00218	CbGpPWpGaD
Estriol—Shock—Doxorubicin—urinary bladder cancer	7.68e-05	0.000937	CcSEcCtD
Estriol—Nervous system disorder—Doxorubicin—urinary bladder cancer	7.66e-05	0.000934	CcSEcCtD
Estriol—Insomnia—Epirubicin—urinary bladder cancer	7.63e-05	0.000931	CcSEcCtD
Estriol—Skin disorder—Doxorubicin—urinary bladder cancer	7.58e-05	0.000925	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—NCOR1—urinary bladder cancer	7.56e-05	0.00214	CbGpPWpGaD
Estriol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	7.52e-05	0.00213	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	7.51e-05	0.00213	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.5e-05	0.00213	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.48e-05	0.00212	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	7.45e-05	0.00211	CbGpPWpGaD
Estriol—Dyspepsia—Epirubicin—urinary bladder cancer	7.43e-05	0.000906	CcSEcCtD
Estriol—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	7.39e-05	0.0021	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	7.37e-05	0.00209	CbGpPWpGaD
Estriol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	7.37e-05	0.0009	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	7.34e-05	0.00208	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	7.3e-05	0.00207	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	7.28e-05	0.000889	CcSEcCtD
Estriol—Pain—Epirubicin—urinary bladder cancer	7.22e-05	0.000881	CcSEcCtD
Estriol—Urticaria—Methotrexate—urinary bladder cancer	7.16e-05	0.000874	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	7.16e-05	0.00203	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	7.15e-05	0.00203	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.14e-05	0.00202	CbGpPWpGaD
Estriol—Abdominal pain—Methotrexate—urinary bladder cancer	7.13e-05	0.00087	CcSEcCtD
Estriol—Insomnia—Doxorubicin—urinary bladder cancer	7.06e-05	0.000862	CcSEcCtD
Estriol—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	7.01e-05	0.00199	CbGpPWpGaD
Estriol—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	7e-05	0.00198	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.94e-05	0.00197	CbGpPWpGaD
Estriol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	6.9e-05	0.000842	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.88e-05	0.00195	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTZ1—urinary bladder cancer	6.87e-05	0.00195	CbGpPWpGaD
Estriol—Dyspepsia—Doxorubicin—urinary bladder cancer	6.87e-05	0.000839	CcSEcCtD
Estriol—ESR2—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	6.81e-05	0.00193	CbGpPWpGaD
Estriol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	6.74e-05	0.000823	CcSEcCtD
Estriol—Urticaria—Epirubicin—urinary bladder cancer	6.7e-05	0.000818	CcSEcCtD
Estriol—Pain—Doxorubicin—urinary bladder cancer	6.68e-05	0.000815	CcSEcCtD
Estriol—Abdominal pain—Epirubicin—urinary bladder cancer	6.67e-05	0.000814	CcSEcCtD
Estriol—Hypersensitivity—Methotrexate—urinary bladder cancer	6.64e-05	0.000811	CcSEcCtD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	6.57e-05	0.00186	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	6.54e-05	0.00185	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	6.53e-05	0.00185	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTO2—urinary bladder cancer	6.52e-05	0.00185	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NAT1—urinary bladder cancer	6.52e-05	0.00185	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.41e-05	0.00182	CbGpPWpGaD
Estriol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	6.38e-05	0.000779	CcSEcCtD
Estriol—Pruritus—Methotrexate—urinary bladder cancer	6.38e-05	0.000778	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	6.35e-05	0.0018	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	6.33e-05	0.00179	CbGpPWpGaD
Estriol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	6.23e-05	0.00177	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.22e-05	0.00176	CbGpPWpGaD
Estriol—Hypersensitivity—Epirubicin—urinary bladder cancer	6.22e-05	0.000759	CcSEcCtD
Estriol—Urticaria—Doxorubicin—urinary bladder cancer	6.2e-05	0.000757	CcSEcCtD
Estriol—Abdominal pain—Doxorubicin—urinary bladder cancer	6.17e-05	0.000753	CcSEcCtD
Estriol—Diarrhoea—Methotrexate—urinary bladder cancer	6.17e-05	0.000753	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.08e-05	0.00172	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	6.08e-05	0.00172	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	6.05e-05	0.00172	CbGpPWpGaD
Estriol—Pruritus—Epirubicin—urinary bladder cancer	5.97e-05	0.000728	CcSEcCtD
Estriol—Dizziness—Methotrexate—urinary bladder cancer	5.96e-05	0.000728	CcSEcCtD
Estriol—SLCO1A2—Metabolism—UGT2B7—urinary bladder cancer	5.96e-05	0.00169	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	5.96e-05	0.00169	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—ESR1—urinary bladder cancer	5.94e-05	0.00168	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.79e-05	0.00164	CbGpPWpGaD
Estriol—Diarrhoea—Epirubicin—urinary bladder cancer	5.77e-05	0.000705	CcSEcCtD
Estriol—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.75e-05	0.000702	CcSEcCtD
Estriol—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	5.75e-05	0.00163	CbGpPWpGaD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.74e-05	0.00163	CbGpPWpGaD
Estriol—Vomiting—Methotrexate—urinary bladder cancer	5.73e-05	0.0007	CcSEcCtD
Estriol—Rash—Methotrexate—urinary bladder cancer	5.68e-05	0.000694	CcSEcCtD
Estriol—Dermatitis—Methotrexate—urinary bladder cancer	5.68e-05	0.000693	CcSEcCtD
Estriol—Headache—Methotrexate—urinary bladder cancer	5.65e-05	0.000689	CcSEcCtD
Estriol—Dizziness—Epirubicin—urinary bladder cancer	5.58e-05	0.000681	CcSEcCtD
Estriol—SLCO1A2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	5.54e-05	0.00157	CbGpPWpGaD
Estriol—Pruritus—Doxorubicin—urinary bladder cancer	5.52e-05	0.000674	CcSEcCtD
Estriol—ESR2—Generic Transcription Pathway—PPARG—urinary bladder cancer	5.42e-05	0.00154	CbGpPWpGaD
Estriol—ESR2—Gene Expression—SMC1A—urinary bladder cancer	5.41e-05	0.00153	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CYP4B1—urinary bladder cancer	5.37e-05	0.00152	CbGpPWpGaD
Estriol—Vomiting—Epirubicin—urinary bladder cancer	5.36e-05	0.000655	CcSEcCtD
Estriol—Nausea—Methotrexate—urinary bladder cancer	5.36e-05	0.000654	CcSEcCtD
Estriol—Diarrhoea—Doxorubicin—urinary bladder cancer	5.34e-05	0.000652	CcSEcCtD
Estriol—Rash—Epirubicin—urinary bladder cancer	5.32e-05	0.000649	CcSEcCtD
Estriol—Dermatitis—Epirubicin—urinary bladder cancer	5.32e-05	0.000649	CcSEcCtD
Estriol—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	5.31e-05	0.00151	CbGpPWpGaD
Estriol—Headache—Epirubicin—urinary bladder cancer	5.29e-05	0.000645	CcSEcCtD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	5.28e-05	0.0015	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	5.26e-05	0.00149	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	5.22e-05	0.00148	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—CREBBP—urinary bladder cancer	5.2e-05	0.00148	CbGpPWpGaD
Estriol—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	5.2e-05	0.00147	CbGpPWpGaD
Estriol—Dizziness—Doxorubicin—urinary bladder cancer	5.16e-05	0.00063	CcSEcCtD
Estriol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.11e-05	0.00145	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—SLC19A1—urinary bladder cancer	5.07e-05	0.00144	CbGpPWpGaD
Estriol—Nausea—Epirubicin—urinary bladder cancer	5.01e-05	0.000612	CcSEcCtD
Estriol—Vomiting—Doxorubicin—urinary bladder cancer	4.96e-05	0.000606	CcSEcCtD
Estriol—SLCO1A2—Metabolism—PRSS3—urinary bladder cancer	4.94e-05	0.0014	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	4.94e-05	0.0014	CbGpPWpGaD
Estriol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	4.93e-05	0.0014	CbGpPWpGaD
Estriol—Rash—Doxorubicin—urinary bladder cancer	4.92e-05	0.000601	CcSEcCtD
Estriol—Dermatitis—Doxorubicin—urinary bladder cancer	4.92e-05	0.0006	CcSEcCtD
Estriol—Headache—Doxorubicin—urinary bladder cancer	4.89e-05	0.000597	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	4.72e-05	0.00134	CbGpPWpGaD
Estriol—Nausea—Doxorubicin—urinary bladder cancer	4.64e-05	0.000566	CcSEcCtD
Estriol—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	4.55e-05	0.00129	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	4.54e-05	0.00129	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	4.53e-05	0.00128	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	4.5e-05	0.00128	CbGpPWpGaD
Estriol—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	4.45e-05	0.00126	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.42e-05	0.00125	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	4.34e-05	0.00123	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.33e-05	0.00123	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	4.31e-05	0.00122	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	4.3e-05	0.00122	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	4.18e-05	0.00119	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	4.11e-05	0.00116	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.96e-05	0.00112	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TYMP—urinary bladder cancer	3.95e-05	0.00112	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.91e-05	0.00111	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	3.81e-05	0.00108	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.79e-05	0.00108	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	3.78e-05	0.00107	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.78e-05	0.00107	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.77e-05	0.00107	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	3.7e-05	0.00105	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	3.68e-05	0.00104	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	3.64e-05	0.00103	CbGpPWpGaD
Estriol—ESR2—Gene Expression—NCOR1—urinary bladder cancer	3.64e-05	0.00103	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.6e-05	0.00102	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NAT2—urinary bladder cancer	3.57e-05	0.00101	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	3.51e-05	0.000996	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.5e-05	0.000992	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	3.5e-05	0.000991	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	3.48e-05	0.000986	CbGpPWpGaD
Estriol—ESR2—Gene Expression—ERCC2—urinary bladder cancer	3.42e-05	0.00097	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	3.22e-05	0.000912	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	3.2e-05	0.000908	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	3.19e-05	0.000904	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	3.19e-05	0.000904	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	3.14e-05	0.000889	CbGpPWpGaD
Estriol—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	3.13e-05	0.000888	CbGpPWpGaD
Estriol—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	3.11e-05	0.000881	CbGpPWpGaD
Estriol—ESR2—Generic Transcription Pathway—MYC—urinary bladder cancer	3.09e-05	0.000876	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—RRM2—urinary bladder cancer	3.08e-05	0.000874	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	3.07e-05	0.00087	CbGpPWpGaD
Estriol—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	2.96e-05	0.000838	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	2.94e-05	0.000835	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.92e-05	0.000828	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.9e-05	0.000821	CbGpPWpGaD
Estriol—ESR2—Gene Expression—ESR1—urinary bladder cancer	2.86e-05	0.000811	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ENO2—urinary bladder cancer	2.85e-05	0.000809	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—HPGDS—urinary bladder cancer	2.85e-05	0.000809	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.84e-05	0.000805	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	2.79e-05	0.000793	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTO2—urinary bladder cancer	2.79e-05	0.000791	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NAT1—urinary bladder cancer	2.79e-05	0.000791	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTT1—urinary bladder cancer	2.77e-05	0.000785	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	2.76e-05	0.000783	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	2.73e-05	0.000775	CbGpPWpGaD
Estriol—ESR1—Gene Expression—SMC1A—urinary bladder cancer	2.73e-05	0.000773	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.73e-05	0.000773	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	2.67e-05	0.000758	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	2.62e-05	0.000744	CbGpPWpGaD
Estriol—ESR2—Gene Expression—PPARG—urinary bladder cancer	2.61e-05	0.00074	CbGpPWpGaD
Estriol—SLCO1A2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	2.59e-05	0.000735	CbGpPWpGaD
Estriol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.57e-05	0.00073	CbGpPWpGaD
Estriol—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	2.55e-05	0.000724	CbGpPWpGaD
Estriol—ESR2—Gene Expression—CREBBP—urinary bladder cancer	2.51e-05	0.00071	CbGpPWpGaD
Estriol—ESR1—Gene Expression—ESR2—urinary bladder cancer	2.38e-05	0.000674	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	2.37e-05	0.000672	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	2.34e-05	0.000664	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NQO1—urinary bladder cancer	2.3e-05	0.000652	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	2.3e-05	0.000651	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	2.29e-05	0.000649	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.23e-05	0.000633	CbGpPWpGaD
Estriol—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	2.17e-05	0.000615	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.11e-05	0.0006	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.07e-05	0.000586	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2e-05	0.000567	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2e-05	0.000566	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.95e-05	0.000552	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTP1—urinary bladder cancer	1.92e-05	0.000544	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.9e-05	0.00054	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.86e-05	0.000527	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.85e-05	0.000525	CbGpPWpGaD
Estriol—ESR1—Gene Expression—NCOR1—urinary bladder cancer	1.84e-05	0.00052	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	1.83e-05	0.000519	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—TYMS—urinary bladder cancer	1.78e-05	0.000506	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—NCOR1—urinary bladder cancer	1.76e-05	0.0005	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GSTM1—urinary bladder cancer	1.76e-05	0.0005	CbGpPWpGaD
Estriol—ESR1—Gene Expression—ERCC2—urinary bladder cancer	1.73e-05	0.000489	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	1.72e-05	0.000488	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TYMP—urinary bladder cancer	1.69e-05	0.000479	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—GPX1—urinary bladder cancer	1.69e-05	0.000479	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.66e-05	0.00047	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—ERCC2—urinary bladder cancer	1.66e-05	0.00047	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	1.64e-05	0.000465	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.62e-05	0.00046	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—MTHFR—urinary bladder cancer	1.56e-05	0.000442	CbGpPWpGaD
Estriol—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	1.56e-05	0.000442	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.55e-05	0.000438	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.53e-05	0.000435	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NAT2—urinary bladder cancer	1.53e-05	0.000433	CbGpPWpGaD
Estriol—ESR2—Gene Expression—MYC—urinary bladder cancer	1.49e-05	0.000422	CbGpPWpGaD
Estriol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.36e-05	0.000386	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—S100B—urinary bladder cancer	1.33e-05	0.000376	CbGpPWpGaD
Estriol—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.32e-05	0.000374	CbGpPWpGaD
Estriol—ESR1—Gene Expression—PPARG—urinary bladder cancer	1.32e-05	0.000373	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.26e-05	0.000358	CbGpPWpGaD
Estriol—ESR1—Gene Expression—CREBBP—urinary bladder cancer	1.26e-05	0.000358	CbGpPWpGaD
Estriol—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	0.000347	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.22e-05	0.000347	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.21e-05	0.000344	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	1.19e-05	0.000338	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.19e-05	0.000336	CbGpPWpGaD
Estriol—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.11e-05	0.000315	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TERT—urinary bladder cancer	1.05e-05	0.000298	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	9.94e-06	0.000282	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NQO1—urinary bladder cancer	9.85e-06	0.000279	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	9.65e-06	0.000274	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	8.67e-06	0.000246	CbGpPWpGaD
Estriol—SLCO1A2—Metabolism—EP300—urinary bladder cancer	8.27e-06	0.000234	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTP1—urinary bladder cancer	8.22e-06	0.000233	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	8.21e-06	0.000233	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	8.11e-06	0.00023	CbGpPWpGaD
Estriol—ABCB1—Metabolism—TYMS—urinary bladder cancer	7.64e-06	0.000217	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GSTM1—urinary bladder cancer	7.55e-06	0.000214	CbGpPWpGaD
Estriol—ABCB1—Metabolism—NCOR1—urinary bladder cancer	7.55e-06	0.000214	CbGpPWpGaD
Estriol—ESR1—Gene Expression—MYC—urinary bladder cancer	7.5e-06	0.000213	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	7.43e-06	0.000211	CbGpPWpGaD
Estriol—ABCB1—Metabolism—GPX1—urinary bladder cancer	7.23e-06	0.000205	CbGpPWpGaD
Estriol—ABCB1—Metabolism—ERCC2—urinary bladder cancer	7.1e-06	0.000201	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	6.88e-06	0.000195	CbGpPWpGaD
Estriol—ABCB1—Metabolism—MTHFR—urinary bladder cancer	6.67e-06	0.000189	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	6.52e-06	0.000185	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—IL2—urinary bladder cancer	6.23e-06	0.000177	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	6.08e-06	0.000172	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	5.9e-06	0.000167	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	5.88e-06	0.000167	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	5.87e-06	0.000166	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EP300—urinary bladder cancer	5.59e-06	0.000159	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—SRC—urinary bladder cancer	5.44e-06	0.000154	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PPARG—urinary bladder cancer	5.41e-06	0.000153	CbGpPWpGaD
Estriol—ABCB1—Metabolism—CREBBP—urinary bladder cancer	5.2e-06	0.000147	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—MYC—urinary bladder cancer	4.88e-06	0.000138	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	4.77e-06	0.000135	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	4.5e-06	0.000128	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTGS2—urinary bladder cancer	4.26e-06	0.000121	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—TP53—urinary bladder cancer	4e-06	0.000114	CbGpPWpGaD
Estriol—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	3.83e-06	0.000109	CbGpPWpGaD
Estriol—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.71e-06	0.000105	CbGpPWpGaD
Estriol—ABCB1—Metabolism—EP300—urinary bladder cancer	3.54e-06	0.0001	CbGpPWpGaD
